These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31202462)

  • 1. Basic helix-loop-helix transcription factor Twist1 is a novel regulator of anterior gradient protein 2 homolog (AGR2) in breast cancer.
    Jung SY; Yun J; Kim SJ; Kang S; Kim DY; Kim YJ; Park JH; Jang WB; Ji ST; Ha JS; Hong Van LT; Truong Giang LT; Rethineswaran VK; Kim DH; Song P; Kwon SM
    Biochem Biophys Res Commun; 2019 Aug; 516(1):149-156. PubMed ID: 31202462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.
    Xiu B; Chi Y; Liu L; Chi W; Zhang Q; Chen J; Guo R; Si J; Li L; Xue J; Shao ZM; Wu ZH; Huang S; Wu J
    Mol Cancer; 2019 Dec; 18(1):187. PubMed ID: 31856843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior gradient 2 promotes tumorigenesis through upregulation of CCAAT-enhancer binding protein beta and hypoxia-inducible factor-2α and subsequent secretion of interleukin-6, interleukin-8, and vascular endothelial growth factor in the Caki-1 clear cell renal cell carcinoma cell line.
    Pajdzik K; Wilamowski M; Żurawek D; Stopa KB; Nodzyński M; Kalita A; Jura J
    IUBMB Life; 2020 Aug; 72(8):1807-1818. PubMed ID: 32593213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
    Pei XH; Lv XQ; Li HX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
    Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
    Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular AGR2 triggers lung tumour cell proliferation through repression of p21
    Fessart D; de Barbeyrac C; Boutin I; Grenier T; Richard E; Begueret H; Bernard D; Chevet E; Robert J; Delom F
    Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118920. PubMed ID: 33278424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells.
    Yeh TC; Huang TT; Yeh TS; Chen YR; Hsu KW; Yin PH; Lee HC; Tseng LM
    PLoS One; 2016; 11(12):e0168171. PubMed ID: 27930738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of targets of Twist1 transcription factor in thyroid cancer cells.
    Di Maro G; Orlandella FM; Bencivenga TC; Salerno P; Ugolini C; Basolo F; Maestro R; Salvatore G
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1617-26. PubMed ID: 24848707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AGR2-induced glucose metabolism facilitated the progression of endometrial carcinoma via enhancing the MUC1/HIF-1α pathway.
    Gong W; Ekmu B; Wang X; Lu Y; Wan L
    Hum Cell; 2020 Jul; 33(3):790-800. PubMed ID: 32304027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ER-resident and secreted AGR2 on cell proliferation, migration, invasion, and survival in PANC-1 pancreatic cancer cells.
    Hong X; Li ZX; Hou J; Zhang HY; Zhang CY; Zhang J; Sun H; Pang LH; Wang T; Deng ZH
    BMC Cancer; 2021 Jan; 21(1):33. PubMed ID: 33413231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
    Cho KH; Yu SL; Cho DY; Park CG; Lee HY
    BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.
    Salmans ML; Zhao F; Andersen B
    Breast Cancer Res; 2013 Apr; 15(2):204. PubMed ID: 23635006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells.
    Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D
    Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGR2 is controlled by DNMT3a-centered signaling module and mediates tumor resistance to 5-Aza in colorectal cancer.
    Li J; Hu J; Luo Z; Zhou C; Huang L; Zhang H; Chi J; Chen Z; Li Q; Deng M; Chen J; Tao K; Wang G; Wang L; Wang Z
    Exp Cell Res; 2019 Dec; 385(1):111644. PubMed ID: 31614132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior gradient 2 is a novel pro-tumor factor in pancreatic cancer under NF-κB subunit RelA trans-regulation that can be suppressed by eugenic acid.
    Huang L; Yang C; Wang Y; Li G; Pan J; Luo H; Wu Z; Tian Y; Chen S; Chen J; Jian Z
    Biomed Pharmacother; 2020 Dec; 132():110830. PubMed ID: 33059262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
    Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
    Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Special AT-rich sequence-binding protein-1 participates in the maintenance of breast cancer stem cells through regulation of the Notch signaling pathway and expression of Snail1 and Twist1.
    Sun Z; Zhang C; Zou X; Jiang G; Xu Z; Li W; Xie H
    Mol Med Rep; 2015 May; 11(5):3235-542. PubMed ID: 25586771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.